Loza F. Tadesse

Loza F. Tadesse

Auto-generated profile, based on publicly available information

Loza F. Tadesse

Department of Mechanical Engineering

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2020 in Nano Letters
Verified
Journal Article
Open access
LTLoza F. Tadesse
Loza F. Tadesse
CHChi-Sing Ho
Chi-Sing Ho
DCDong-Hua Chen
Dong-Hua Chen
HAHamed Arami
Hamed Arami
NBNiaz Banaei
Niaz Banaei
JDJennifer A. Dionne
Jennifer A. Dionne
Surface-enhanced Raman spectroscopy (SERS) is a promising cellular identification and drug susceptibility testing platform, provided it can be performed in a controlled liquid environment that maintains cell viability. We investigate bacterial liquid-SERS, studying plasmonic and electrostatic interactions between gold nanorods and bacteria that enable uniformly-enhanced SERS. We synthesize five nanorod sizes with longitudinal plasmon resonances ranging from 670-860 nm and characterize SERS signatures of Gram-negative Escherichia coli and Serratia marcescens, and Gram-positive Staphylococcus aureus and Staphylococcus epidermidis bacteria in water. Varying the concentration of bacteria and nanorods, we achieve large-area SERS enhancement that is independent of nanorod resonance and bacteria type; however, bacteria with higher surface charge density exhibit significantly higher SERS signal. Using cryo-electron microscopy and zeta potential measurements, we show that higher signal results from attraction between positively-charged nanorods and negatively-charged bacteria. Our robust liquid-SERS measurements provide a foundation for bacterial identification and drug testing in biological fluids.

28 June 2020 in The Journal of Chemical Physics
Verified
Journal Article
Open access
LTLoza F. Tadesse
Loza F. Tadesse
FSFareeha Safir
Fareeha Safir
CHChi-Sing Ho
Chi-Sing Ho
XHXimena Hasbach
Ximena Hasbach
BKButrus T. Khuri-Yakub
Butrus T. Khuri-Yakub
JDJennifer A. Dionne
Jennifer A. Dionne
In a pandemic era, rapid infectious disease diagnosis is essential. Surface-enhanced Raman spectroscopy (SERS) promises sensitive and specific diagnosis including rapid point-of-care detection and drug susceptibility testing. SERS utilizes inelastic light scattering arising from the interaction of incident photons with molecular vibrations, enhanced by orders of magnitude with resonant metallic or dielectric nanostructures. While SERS provides a spectral fingerprint of the sample, clinical translation is lagged due to challenges in consistency of spectral enhancement, complexity in spectral interpretation, insufficient specificity and sensitivity, and inefficient workflow from patient sample collection to spectral acquisition. Here, we highlight the recent, complementary advances that address these shortcomings, including (1) design of label-free SERS substrates and data processing algorithms that improve spectral signal and interpretability, essential for broad pathogen screening assays; (2) development of new capture and affinity agents, such as aptamers and polymers, critical for determining the presence or absence of particular pathogens; and (3) microfluidic and bioprinting platforms for efficient clinical sample processing. We also describe the development of low-cost, point-of-care, optical SERS hardware. Our paper focuses on SERS for viral and bacterial detection, in hopes of accelerating infectious disease diagnosis, monitoring, and vaccine development. With advances in SERS substrates, machine learning, and microfluidics and bioprinting, the specificity, sensitivity, and speed of SERS can be readily translated from laboratory bench to patient bedside, accelerating point-of-care diagnosis, personalized medicine, and precision health.

11 June 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
BOBabatunde Ogunlade
Babatunde Ogunlade
LTLoza F. Tadesse
Loza F. Tadesse
HLHongquan Li
Hongquan Li
NVNhat Vu
Nhat Vu
NBNiaz Banaei
Niaz Banaei
JDJennifer A. Dionne
Jennifer A. Dionne
Tuberculosis (TB) is the world’s deadliest infectious disease, with over 1.5 million deaths and 10 million new cases reported anually. The causative organismMycobacterium tuberculosis(Mtb) can take nearly 40 d to culture, a required step to determine the pathogen’s antibiotic susceptibility. Both rapid identification and rapid antibiotic susceptibility testing of Mtb are essential for effective patient treatment and combating antimicrobial resistance. Here, we demonstrate a rapid, culture-free, and antibiotic incubation-free drug susceptibility test for TB using Raman spectroscopy and machine learning. We collect few-to-single-cell Raman spectra from over 25,000 cells of the Mtb complex strain Bacillus Calmette-Guérin (BCG) resistant to one of the four mainstay anti-TB drugs, isoniazid, rifampicin, moxifloxacin, and amikacin, as well as a pan-susceptible wildtype strain. By training a neural network on this data, we classify the antibiotic resistance profile of each strain, both on dried samples and on patient sputum samples. On dried samples, we achieve >98% resistant versus susceptible classification accuracy across all five BCG strains. In patient sputum samples, we achieve ~79% average classification accuracy. We develop a feature recognition algorithm in order to verify that our machine learning model is using biologically relevant spectral features to assess the resistance profiles of our mycobacterial strains. Finally, we demonstrate how this approach can be deployed in resource-limited settings by developing a low-cost, portable Raman microscope that costs <$5,000. We show how this instrument and our machine learning model enable combined microscopy and spectroscopy for accurate few-to-single-cell drug susceptibility testing of BCG.

17 January 2017 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
DODahyun Oh
Dahyun Oh
KVKumar Virwani
Kumar Virwani
LTLoza Tadesse
Loza Tadesse
MJMark Jurich
Mark Jurich
NANagaphani B. Aetukuri
Nagaphani B. Aetukuri
DBDonald S. Bethune
Donald S. Bethune


29 August 2023 in Journal of Raman Spectroscopy
Verified
Journal Article
Open access
Jongwan LeeJongwan Lee
Jongwan Lee
MMMarissa McDonald
Marissa McDonald
NMNikiwe Mhlanga
Nikiwe Mhlanga
JKJeon Woong Kang
Jeon Woong Kang
RKRohit Karnik
Rohit Karnik
LTLoza F. Tadesse
Loza F. Tadesse
Dynabeads are superparamagnetic particles used for the immunomagnetic purification of cells and biomolecules. Post‐capture, however, target identification relies on tedious culturing, fluorescence staining, and/or target amplification. Raman spectroscopy presents a rapid detection alternative, but current implementations target cells themselves with weak Raman signals. We present antibody‐coated Dynabeads as strong Raman reporter labels whose effect can be considered a Raman parallel of immunofluorescent probes. Recent developments in techniques for separating target‐bound Dynabeads from unbound Dynabeads make such an implementation feasible with high specificity. We deploy Dynabeads anti‐Salmonella to bind and identify Salmonella enterica, a major foodborne pathogen. Dynabeads present major peaks around 1000 and 1600 cm−1 from aliphatic and aromatic C‐C stretching of the polystyrene coating and near 1350 cm−1 from the ɣ‐Fe2O3 and Fe3O4 core, confirmed with electron dispersive X‐ray (EDX) imaging. Minor to no contributions are made from the surface antibodies themselves as confirmed by Raman analysis of surface‐activated, antibody‐free beads. Dynabeads' Raman signature can be measured in dry and liquid samples even at single shot ~30 × 30 μm area imaging using 0.5 s, 7‐mW laser acquisition with single and clustered beads providing a 44‐ and 68‐fold larger Raman intensity compared with the signature from cells. Higher polystyrene and iron oxide content in clusters yields larger signal intensity, and conjugation to bacteria strengthens clustering as a bacterium can bind to more than one bead as observed via transmission electron microscopy (TEM). Our findings shed light on the intrinsic Raman reporter nature of Dynabeads. When combined with emerging techniques for the separation of target‐bound Dynabeads from unbound Dynabeads such as using centrifugation through a density media bilayer, they have the potential to demonstrate their dual function for target isolation and detection without tedious staining steps or unique plasmonic substrate engineering, advancing their applications in heterogeneous samples like food, water, and blood.